Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma.

@article{Stylli1995AluminiumPM,
  title={Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma.},
  author={Stanley S. Stylli and Jamal Hill and Will Sawyer and Andrew H. Kaye},
  journal={Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia},
  year={1995},
  volume={2 2},
  pages={146-51}
}
The efficacy of aluminium tetrasulfonated phthalocyanine (AISPc) as a photosensitizer for photodynamic therapy (PDT) was investigated in the C6 glioma model in Wistar rats. The depth and extent of tumour necrosis was dependent on both the dosage of intravenously (IV) administered AISPc, and the dose and time post-sensitization of 675 nm light administration. There was no effect on tumour or normal brain if the sensitizer dose was less than 0.5 mg/kg. Selective necrosis of tumour was evident 6… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 34 references

The use of phthalocyanines as potential photosensitizers in the laboratory investigations treatment of central nervous system neoplasms.] Clinical Neuroscience 1995;(in press)

  • SS Stylli, HillS, WH Sawyer, AH Kaye
  • 1995

The use of phthalocyanines as potential photosensitizers in the treatment of central nervous system neoplasms

  • SS Stylli, HillJS, WH Sawyer, AH Kaye
  • J Clinical Neuroscience
  • 1995

Photodynamic therapy of cerebral tumours

  • AH Kaye, HillS
  • Neurosurgery Quarterly
  • 1992

Yearly Review: Phthalocyanines as photodynamic sensitizers

  • Rosenthal
  • Photochem Photobiol
  • 1991

Similar Papers

Loading similar papers…